Canadian cannabis producer Organigram reported net revenue of C$162 million ($123m) for its fiscal 2023 ended in September, an 11% rise over the previous year. Adjusted EBITDA roughly doubled to C$6 ...

The top wineries of the region sell futures the spring after harvest, while the wines are still aging in barrels. They get cash up front to help them cover production costs. The négociants—as … Contin ...

In the second part of our interview, Breakthru Beverage co-chairmen Charlie Merinoff and Danny Wirtz discuss the national accounts landscape, efforts in the e-commerce sphere, and the leadership ...

The Drug Enforcement Agency (DEA) could issue an announcement on the rescheduling of cannabis from a Schedule I drug as soon as this week, according to comments from opposition group Smart Approaches ...

SND: How are overall business conditions at Stew Leonard’s at the moment? What consumer buying trends jump out to you? Leonard: There is a huge uptick in business right now. Customers are getting ...

Canadian cannabis use has continued to tick up significantly in recent years, according to government statistics agency StatCan. Sales of recreational cannabis by provincial authorities and other ...

Toronto-based Organigram has received a new C$124.6 million ($91.3 million) investment from British American Tobacco (BAT) as it eyes expansion opportunities. The company plans to use about two-thirds ...

Winebow has undergone a sweeping transformation in recent years, assembling a bicoastal wholesale presence while continuing to build its portfolio of imported wines and spirits. The Virginia-based ...

During its first quarter-century in business, Deutsch Family Wine & Spirits forged its reputation as one of America’s top wine importers, having built first Georges Duboeuf (now handled by ...

Campari Group has closed its previously announced acquisition of Courvoisier Cognac from Beam Suntory for up to $1.3 billion. The deal includes an initial $1.2 billion and an earnout of up to $120 ...

Earlier this year, William Grant & Sons appointed Paul Basford as president and managing director of its U.S. business, which has annual volume of 3 million cases, according to Impact Databank.

As predicted in today’s SND Cannabis Edition, the Drug Enforcement Agency (DEA) has agreed to transfer cannabis from a Schedule I to a Schedule III drug, placing it in line with substances like ...